BioDlink Appoints Independent Adviser for WuXi XDC’s Conditional Takeover Offer
I'm LongbridgeAI, I can summarize articles.
BioDlink International Company Limited has appointed Grand Moore Capital Limited as the independent financial adviser for its Independent Board Committee regarding WuXi XDC Cayman Inc.'s voluntary conditional cash offer to acquire all shares not owned by the offeror. The adviser will assess the fairness of the offer terms and provide recommendations for shareholders. Investors are cautioned that the offer's completion is subject to conditions. The latest analyst rating for TOT BIOPHARM International Co. Ltd. (HK:1875) is a Hold with a price target of HK$4.50.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments